Ormetoprim

Ormetoprim

Ormetoprim is a dihydrofolate reductase inhibitor used in combination with sulfonamides to enhance their antibacterial activity. This combination works synergistically, meaning that the effect of the two drugs together is greater than the sum of their effects when used separately. Ormetoprim, by inhibiting the enzyme dihydrofolate reductase, prevents the formation of tetrahydrofolate, a compound necessary for the synthesis of purines and thymidylate, which are essential for the production of DNA and RNA. As a result, ormetoprim effectively halts the replication of bacteria, making it a valuable tool in the treatment of bacterial infections.

Usage

Ormetoprim is primarily used in veterinary medicine, often in aquaculture and livestock, to treat a variety of bacterial infections. It is commonly combined with sulfadimethoxine to treat diseases in chickens, turkeys, and swine, and with sulfadiazine in fish. The combination of ormetoprim and sulfadiazine, for example, is used to combat bacterial diseases in salmon and trout, such as furunculosis caused by Aeromonas salmonicida.

Mechanism of Action

The mechanism of action of ormetoprim involves the inhibition of the bacterial enzyme dihydrofolate reductase. This enzyme is crucial for the bacterial cell to synthesize folate, which is necessary for the production of nucleic acids and proteins. By inhibiting this enzyme, ormetoprim effectively starves the bacteria of the components needed for DNA, RNA, and protein synthesis, leading to the bacteria's inability to replicate and ultimately its death.

Combination with Sulfonamides

The combination of ormetoprim with sulfonamides is a classic example of drug synergy. Sulfonamides act by inhibiting another step in the folate synthesis pathway, specifically the conversion of para-aminobenzoic acid (PABA) to dihydropteroate. When used together, ormetoprim and sulfonamides block two sequential steps in the folate synthesis pathway, making it much more difficult for bacteria to bypass the blockage and survive. This combination allows for lower doses of both drugs to be used, reducing the potential for side effects and the development of antibiotic resistance.

Safety and Side Effects

While generally safe and effective when used as directed, ormetoprim can cause side effects in some animals, including gastrointestinal disturbances and allergic reactions. Its use should be carefully considered in animals with known hypersensitivity to sulfonamides or dihydrofolate reductase inhibitors.

Regulatory Status

The regulatory status of ormetoprim varies by country and intended use. In some jurisdictions, it is approved for use in certain animals but not in others, and it may be available only by prescription from a licensed veterinarian.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian